News - Greater Bay Area International Clinical Trial Institute

04.09.2026

GBAICTI Featured in the Latest Episode of RTHK's 港好十五五

We are pleased to be featured in the latest episode of Radio Television Hong Kong (RTHK)'s 港好十五五, which explores how Hong Kong can leverage its strengths in clinical research, regulatory innovation and cross-boundary collaboration to accelerate the development and globalisation of innovative medicines.

24.08.2026

GBAICTI at Global Health Summit 2026: Advancing Healthcare Innovation

The Greater Bay Area International Clinical Trial Institute (GBAICTI) was pleased to participate in the Global Health Summit 2026, joining healthcare leaders, innovators and industry stakeholders from around the world to discuss the future of health and medical innovation.

04.08.2026

Clinical Advancement and Research Excellence (CARE) Summit to be held on 4-5 November 2026

Stay tuned for more conference details.

28.07.2026

GBAICTI, BAY TRIAL and Health Hope Pharma Sign MoU to Advance Clinical Trials and Biomedical Innovation in Hong Kong and the Greater Bay Area

The Greater Bay Area International Clinical Trial Institute (GBAICTI), The Greater Bay Area International Clinical Trials Center (BAY TRIAL) and Health Hope Pharma (HHP) today signed a Memorandum of Understanding (MoU) to establish a strategic collaboration framework for advancing new drug development and conducting international multi-centre clinical trials in Hong Kong and across the wider Guangdong-Hong Kong-Macao Greater Bay Area (GBA).

08.07.2026

GBAICTI and Amgen Collaborate to Advance Healthcare Innovation and Improve Patient Care in Hong Kong

The Greater Bay Area International Clinical Trial Institute (“GBAICTI”) and biotechnology company Amgen today announced their collaboration through the signing of a Memorandum of Understanding to strengthen capabilities and improve patient outcomes in Hong Kong and the wider Greater Bay Area (“GBA”).

25.06.2026

GBAICTI Welcomes the Launch of the Public Consultation on “The First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)”

We welcome the launch of the public consultation on “The First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030)”, a significant milestone that sets out a forward-looking vision and strategic direction for the city’s development. The Plan provides an important framework to support Hong Kong’s high-quality development and its deeper integration into the overall national development agenda.